Adjustment for continuous confounders: an example of how to prevent residual confounding.
Identifieur interne : 000146 ( Main/Corpus ); précédent : 000145; suivant : 000147Adjustment for continuous confounders: an example of how to prevent residual confounding.
Auteurs : Rolf H H. Groenwold ; Olaf H. Klungel ; Douglas G. Altman ; Yolanda Van Der Graaf ; Arno W. Hoes ; Karel G M. MoonsSource :
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [ 1488-2329 ] ; 2013.
English descriptors
- KwdEn :
- Aged (MeSH), Aged, 80 and over (MeSH), Bias (MeSH), Confidence Intervals (MeSH), Confounding Factors, Epidemiologic (MeSH), Epidemiologic Studies (MeSH), Female (MeSH), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza Vaccines (adverse effects), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male (MeSH), Mortality (trends), Netherlands (MeSH), Odds Ratio (MeSH), Risk Assessment (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , adverse effects : Influenza Vaccines.
- geographic : Netherlands.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- trends : Mortality.
- Aged, Aged, 80 and over, Bias, Confidence Intervals, Confounding Factors, Epidemiologic, Epidemiologic Studies, Female, Humans, Male, Odds Ratio, Risk Assessment.
DOI: 10.1503/cmaj.120592
PubMed: 23401401
PubMed Central: PMC3602256
Links to Exploration step
pubmed:23401401Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adjustment for continuous confounders: an example of how to prevent residual confounding.</title><author><name sortKey="Groenwold, Rolf H H" sort="Groenwold, Rolf H H" uniqKey="Groenwold R" first="Rolf H H" last="Groenwold">Rolf H H. Groenwold</name><affiliation><nlm:affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. r.h.h.groenwold@umcutrecht.nl</nlm:affiliation></affiliation></author><author><name sortKey="Klungel, Olaf H" sort="Klungel, Olaf H" uniqKey="Klungel O" first="Olaf H" last="Klungel">Olaf H. Klungel</name></author><author><name sortKey="Altman, Douglas G" sort="Altman, Douglas G" uniqKey="Altman D" first="Douglas G" last="Altman">Douglas G. Altman</name></author><author><name sortKey="Van Der Graaf, Yolanda" sort="Van Der Graaf, Yolanda" uniqKey="Van Der Graaf Y" first="Yolanda" last="Van Der Graaf">Yolanda Van Der Graaf</name></author><author><name sortKey="Hoes, Arno W" sort="Hoes, Arno W" uniqKey="Hoes A" first="Arno W" last="Hoes">Arno W. Hoes</name></author><author><name sortKey="Moons, Karel G M" sort="Moons, Karel G M" uniqKey="Moons K" first="Karel G M" last="Moons">Karel G M. Moons</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23401401</idno><idno type="pmid">23401401</idno><idno type="doi">10.1503/cmaj.120592</idno><idno type="pmc">PMC3602256</idno><idno type="wicri:Area/Main/Corpus">000146</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000146</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Adjustment for continuous confounders: an example of how to prevent residual confounding.</title><author><name sortKey="Groenwold, Rolf H H" sort="Groenwold, Rolf H H" uniqKey="Groenwold R" first="Rolf H H" last="Groenwold">Rolf H H. Groenwold</name><affiliation><nlm:affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. r.h.h.groenwold@umcutrecht.nl</nlm:affiliation></affiliation></author><author><name sortKey="Klungel, Olaf H" sort="Klungel, Olaf H" uniqKey="Klungel O" first="Olaf H" last="Klungel">Olaf H. Klungel</name></author><author><name sortKey="Altman, Douglas G" sort="Altman, Douglas G" uniqKey="Altman D" first="Douglas G" last="Altman">Douglas G. Altman</name></author><author><name sortKey="Van Der Graaf, Yolanda" sort="Van Der Graaf, Yolanda" uniqKey="Van Der Graaf Y" first="Yolanda" last="Van Der Graaf">Yolanda Van Der Graaf</name></author><author><name sortKey="Hoes, Arno W" sort="Hoes, Arno W" uniqKey="Hoes A" first="Arno W" last="Hoes">Arno W. Hoes</name></author><author><name sortKey="Moons, Karel G M" sort="Moons, Karel G M" uniqKey="Moons K" first="Karel G M" last="Moons">Karel G M. Moons</name></author></analytic><series><title level="j">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</title><idno type="eISSN">1488-2329</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Bias (MeSH)</term><term>Confidence Intervals (MeSH)</term><term>Confounding Factors, Epidemiologic (MeSH)</term><term>Epidemiologic Studies (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (adverse effects)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Mortality (trends)</term><term>Netherlands (MeSH)</term><term>Odds Ratio (MeSH)</term><term>Risk Assessment (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Netherlands</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Mortality</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Bias</term><term>Confidence Intervals</term><term>Confounding Factors, Epidemiologic</term><term>Epidemiologic Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Odds Ratio</term><term>Risk Assessment</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23401401</PMID><DateCompleted><Year>2013</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1488-2329</ISSN><JournalIssue CitedMedium="Internet"><Volume>185</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Mar</Month><Day>19</Day></PubDate></JournalIssue><Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title><ISOAbbreviation>CMAJ</ISOAbbreviation></Journal><ArticleTitle>Adjustment for continuous confounders: an example of how to prevent residual confounding.</ArticleTitle><Pagination><MedlinePgn>401-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1503/cmaj.120592</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Groenwold</LastName><ForeName>Rolf H H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. r.h.h.groenwold@umcutrecht.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klungel</LastName><ForeName>Olaf H</ForeName><Initials>OH</Initials></Author><Author ValidYN="Y"><LastName>Altman</LastName><ForeName>Douglas G</ForeName><Initials>DG</Initials></Author><Author ValidYN="Y"><LastName>van der Graaf</LastName><ForeName>Yolanda</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Hoes</LastName><ForeName>Arno W</ForeName><Initials>AW</Initials></Author><Author ValidYN="Y"><LastName>Moons</LastName><ForeName>Karel G M</ForeName><Initials>KG</Initials></Author><Author ValidYN="Y"><CollectiveName>PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies])</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>CMAJ</MedlineTA><NlmUniqueID>9711805</NlmUniqueID><ISSNLinking>0820-3946</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015986" MajorTopicYN="Y">Confounding Factors, Epidemiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016021" MajorTopicYN="N">Epidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Yolanda</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slattery</LastName><ForeName>Jim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rottenkolber</LastName><ForeName>Marietta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hasford</LastName><ForeName>Jorg</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sassenfeld</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Abajo Iglesias</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gil</LastName><ForeName>Miguel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huerta</LastName><ForeName>Consuela</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montero</LastName><ForeName>Dolores</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia-Rodriguez</LastName><ForeName>Luis A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruigomez</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Souverein</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Bakker</LastName><ForeName>Dinny</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Boer</LastName><ForeName>Anthonius</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Groenwold</LastName><ForeName>Rolf</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belitser</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pestman</LastName><ForeName>Wiebe</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roes</LastName><ForeName>Kit</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoes</LastName><ForeName>Arno</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abbing-Karahagopian</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Vries</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Staa</LastName><ForeName>Tjeerd</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Egberts</LastName><ForeName>Antoine C G</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leufkens</LastName><ForeName>Hubertus G M</ForeName><Initials>HG</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>Liset</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klungel</LastName><ForeName>Olaf</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallagher</LastName><ForeName>Arlene</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Deven</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helboe</LastName><ForeName>Per</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyngvig</LastName><ForeName>Jytte</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clemensen</LastName><ForeName>Anne Marie</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Engraff</LastName><ForeName>Tina</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hesse</LastName><ForeName>Ulrik</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poulsen</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weil</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bensouda-Grimaldi</LastName><ForeName>Lamiae</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abenhaim</LastName><ForeName>Lucien</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Robert F</ForeName><Initials>RF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gatto</LastName><ForeName>Nicolle</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bate</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Downey</LastName><ForeName>Gerry F</ForeName><Initials>GF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brauer</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yeboa</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goh</LastName><ForeName>Kah L</ForeName><Initials>KL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tepie</LastName><ForeName>Maurille F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roddam</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Velthuis</LastName><ForeName>Erica</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miret</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johansson</LastName><ForeName>Saga</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Primatesta</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlienger</LastName><ForeName>Raymond</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fortuny</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivero</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quartey</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petri</LastName><ForeName>Hans</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuerch</LastName><ForeName>Marcus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robinson</LastName><ForeName>Jamie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laporte</LastName><ForeName>Joan-Ramon</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ibañez</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabaté</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ballarin</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Solari</LastName><ForeName>Paula</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23401401</ArticleId><ArticleId IdType="pii">cmaj.120592</ArticleId><ArticleId IdType="doi">10.1503/cmaj.120592</ArticleId><ArticleId IdType="pmc">PMC3602256</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur J Epidemiol. 1999 Oct;15(9):773-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10608355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2002 Jan 15;136(2):122-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11790063</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2004 Apr 15;23(7):1159-78</Citation><ArticleIdList><ArticleId IdType="pubmed">15057884</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 1968 Jun;24(2):295-313</Citation><ArticleIdList><ArticleId IdType="pubmed">5683871</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 1992 Sep 30;11(13):1747-58</Citation><ArticleIdList><ArticleId IdType="pubmed">1485057</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 1997 Jul;8(4):429-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9209859</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Respir J. 2009 Jul;34(1):56-62</Citation><ArticleIdList><ArticleId IdType="pubmed">19213779</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2004 Dec 30;23(24):3781-801</Citation><ArticleIdList><ArticleId IdType="pubmed">15580601</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Inf Med. 2005;44(4):561-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16342923</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2006 Jan 15;25(1):127-41</Citation><ArticleIdList><ArticleId IdType="pubmed">16217841</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 May 6;332(7549):1080</Citation><ArticleIdList><ArticleId IdType="pubmed">16675816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Epidemiol. 2008 Oct;18(10):746-51</Citation><ArticleIdList><ArticleId IdType="pubmed">18693038</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009;338:b604</Citation><ArticleIdList><ArticleId IdType="pubmed">19336487</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2004 Dec;57(12):1223-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15617947</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000146 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000146 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippePaysBasV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:23401401
|texte= Adjustment for continuous confounders: an example of how to prevent residual confounding.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:23401401" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a GrippePaysBasV1
| This area was generated with Dilib version V0.6.35. |  |